# OnCo record paper-enasidenib-idh2-stein-blood-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-enasidenib-idh2-stein-blood-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-enasidenib-idh2-stein-blood-2017" ;
  schema:name "Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukaemia"@en ;
  schema:description "Enasidenib, a pill blocking the mutant IDH2 enzyme, produced responses in about four in ten patients with relapsed IDH2-mutated acute myeloid leukaemia by making the leukaemic cells mature, and became the first IDH-targeted drug approved."@en ;
  schema:url <https://onco.cc/key-papers/paper-enasidenib-idh2-stein-blood-2017/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood-2017-04-779405>, <https://pubmed.ncbi.nlm.nih.gov/28588020/> ;
  schema:sameAs <https://doi.org/10.1182/blood-2017-04-779405> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Stein EM, DiNardo CD, Pollyea DA, et al." ;
  onco:cancers <https://onco.cc/cancers/aml-idh/> ;
  onco:drugs <https://onco.cc/drugs/enasidenib/> ;
  onco:journals <https://onco.cc/journals/blood/> .